PROTEIN MODIFICOMICS From Modifications to Clinical Perspectives
Protein Modificomics: From Modifications to Clinical Perspectives comprehensively deals with all of the most recent aspects of post-translational modification (PTM) of proteins, including discussions on diseases involving PTMs, such as Alzheimer's, Huntington's, X-linked spinal muscular at...
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
San Diego, CA
Academic Press
2019
|
| Subjects: | |
| Online Access: | Click Here to View Status and Holdings. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Add Tag MARC
| LEADER | 00000nam#a2200000#i#4501 | ||
|---|---|---|---|
| 001 | wils-944202 | ||
| 005 | 20194319231 | ||
| 008 | 200123t2019 -UK a## ##001 #deng#D | ||
| 020 | # | # | |a 9780128119136 |q paperback |
| 040 | # | # | |a UKMGB |b eng |d UiTM |e rda |
| 041 | 0 | # | |a eng |
| 060 | # | 4 | |a QU 55 |
| 090 | 0 | 0 | |a QU55 |b P9401 2019 |
| 245 | 0 | 0 | |a PROTEIN MODIFICOMICS |b From Modifications to Clinical Perspectives |c Edited by TANVEER ALI DAR, LAISHRAM RAJENDRAKUMAR SINGH. |
| 264 | # | 1 | |a San Diego, CA |b Academic Press |c 2019 |
| 264 | # | 4 | |c ©2019 |
| 300 | # | # | |a xvi, 371 pages |b colour illustrations |c 23 cm. |
| 336 | # | # | |a text |2 rdacontent |
| 337 | # | # | |a unmediated |2 rdamedia |
| 338 | # | # | |a volume |2 rdacarrier |
| 504 | # | # | |a Includes bibliographical references and index |
| 520 | # | # | |a Protein Modificomics: From Modifications to Clinical Perspectives comprehensively deals with all of the most recent aspects of post-translational modification (PTM) of proteins, including discussions on diseases involving PTMs, such as Alzheimer's, Huntington's, X-linked spinal muscular atrophy-2, aneurysmal bone cyst, angelman syndrome and OFC10. The book also discusses the role PTMs play in plant physiology and the production of medicinally important primary and secondary metabolites. The understanding of PTMs in plants helps us enhance the production of these metabolites without greatly altering the genome, providing robust eukaryotic systems for the production and isolation of desired products without considerable downstream and isolation processes. |
| 650 | # | 2 | |a Protein Processing, Post-Translational |
| 700 | 1 | # | |a Dar, Tanveer Ali |e editor |
| 700 | 1 | # | |a Singh, Laishram Rajendrakumar |e editor |
| 856 | 4 | 0 | |z Click Here to View Status and Holdings. |u https://opac.uitm.edu.my/opac/detailsPage/detailsHome.jsp?tid=944202 |
| 998 | # | # | |a 00264#1a002.8.2||00264#1b002.8.4||00300##a003.4.1||00300##b003.6.1||00300##c003.5.1||00520##a007.2||00520##b007.2|| |
Post-translational modification of protein biopharmaceuticals